【摘要】 本文报道了抗癌剂碘油动脉栓塞术(LP—TAE)治疗83例原发性肝癌(PHC)的初步结果。着重介绍了治疗过程中碘油和抗癌剂的用量、二者混合的方法、肝动脉内注药和追加明胶海绵栓塞(GS—TAE)的注意点以及再次行LP—TAE的时机选择。分组讨论了83例PHC患者的疗效。经初步统计表明:LP—TAE对I组小肝癌患者可达治愈的目的,其一、二年积累生存率(寿命表法)均为100％。对Ⅱ组巨块型肝癌患者可达提高生活质量、较长延长生存期的目的,其一、二年累积生存率分别为76.57％、62.62％。对Ⅲ组多发结节型肝癌患者可达减轻痛苦、延长生命的目的,其一、二年年累积生存率分别为52.85％、10.91％。作者还简单分析了影响预后的因素及可能的副作用及其处理。更多还原

【Abstract】 The preliminary result of the treatment of 83 primary hepatocellularcarcinoma (PHC)patients by lipiodol-antic cancer agents transarterkl embolization (LP-TAE) was reported The following points were dirscucssed: (1) The dosage of lipiodol and anticancer agent (2) How to mix the two kinds of drugs. (3) How to infuse the mixture into tumor supplying artery. (4) How to apply gelform spongetrans-arterial embolizatbn(GS-TAE) additionally. (5) How to choose the time for re-embolization. The therapentic effects of these 83 PHC patients were reported in 3 groups: In group I, the small PHC: the preliminary statistical data showed that the Lp-TAE has curable effect, both one-and two-year cumulative survival rate (life-span table method) were 100%. In group Ⅱ, the with patients massive PHC the effect was to improve their life quality and to prolong their life for quite a bng time. Their one-and two-year cumulative survival rate were76.57% and 62.62%respectively. In group Ⅲ, the patients with muhinodular PHC the effect was to relief their symptoms and prolong their life. Their one-and two-year cumulative survival rate were 52.85% and 10.90% .The factors effecting prognosis and the the possible side effects of LP-TAE were discussed also.更多还原